PKA-Mediated Phosphorylation of SFRP4 Promotes Wnt/β-Catenin Activation and Cancer Stemness in Gastric Cancer
Open Access
- 11 June 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (12) , 5572
Abstract
Secreted Frizzled-related protein 4 (SFRP4) has been identified as a patient-level biomarker of the stem-like subtype of gastric cancer (GC), which is associated with poor prognosis and resistance to chemotherapy. Although multiple studies have documented the clinical significance of SFRP4 in GC, its mechanistic role in the stem-like subtype remains incompletely understood. In this study, we elucidate how phosphorylation of SFRP4 by protein kinase A (PKA) converts it into a Wnt signaling agonist. We began with a phosphoproteomic database search to identify candidate kinases that phosphorylate SFRP4. Co-immunoprecipitation assays revealed a direct interaction between PKA and SFRP4, and in vitro kinase assays confirmed that PKA phosphorylates SFRP4 at key threonine residues. Phosphorylated SFRP4 then associates with β-catenin, augmenting Wnt-driven transcriptional activity. Importantly, pharmacological inhibition of PKA significantly reduced SFRP4 phosphorylation and suppressed stemness-associated phenotypes, such as sphere formation, migratory capacity, and chemoresistance, in gastric cancer cells. Collectively, our data demonstrate that PKA-mediated phosphorylation of SFRP4 enhances cancer stemness-related properties in GC through Wnt signaling. Furthermore, these results highlight the PKA–SFRP4 axis as a promising therapeutic target in the stem-like subtype of GC.Keywords
Funding Information
- National Research Foundation of Korea (10.13039/501100003725, 10.13039/501100014188, 2710018369, RS-2024-00438316, 10.13039/501100003052, 10.13039/501100003662, RS-2024-00410585)
- Korean Ministry of Science and ICT (10.13039/501100003725, 10.13039/501100014188, 2710018369, RS-2024-00438316, 10.13039/501100003052, 10.13039/501100003662, RS-2024-00410585)
- Ministry of Trade, Industry and Energy (10.13039/501100003725, 10.13039/501100014188, 2710018369, RS-2024-00438316, 10.13039/501100003052, 10.13039/501100003662, RS-2024-00410585)
- Korea Planning and Evaluation Institute of Industrial Technology (10.13039/501100003725, 10.13039/501100014188, 2710018369, RS-2024-00438316, 10.13039/501100003052, 10.13039/501100003662, RS-2024-00410585)
- Encouragement Program for Technology Development (10.13039/501100003725, 10.13039/501100014188, 2710018369, RS-2024-00438316, 10.13039/501100003052, 10.13039/501100003662, RS-2024-00410585)
This publication has 39 references indexed in Scilit:
- SFRP4 drives invasion in gastric cancer and is an early predictor of recurrenceGastric Cancer, 2020
- GPS 5.0: An Update on the Prediction of Kinase-Specific Phosphorylation Sites in ProteinsGenomics, Proteomics & Bioinformatics, 2020
- Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapyCell Biology and Toxicology, 2019
- SFRPs Are Biphasic Modulators of Wnt-Signaling-Elicited Cancer Stem Cell Properties beyond Extracellular ControlCell Reports, 2019
- Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysisThe Lancet Oncology, 2018
- Metabolic stress induces a Wnt-dependent cancer stem cell-like state transitionCell Death & Disease, 2015
- Comprehensive molecular characterization of gastric adenocarcinomaNature, 2014
- Frizzled 5 Signaling Governs the Neural Potential of Progenitors in the Developing Xenopus RetinaNeuron, 2005
- Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancerNature Genetics, 2004
- The Mouse Locus Encodes Axin, an Inhibitor of the Wnt Signaling Pathway That Regulates Embryonic Axis FormationCell, 1997